HOME    SEARCH    ABOUT US    CONTACT US    HELP   
           
This is an obsolete version of the rule. Please click on the rule number to view the current version.

37.114.313    CONFIRMATION OF DISEASE

(1) Subject to the limitation in (2), if a local health officer receives information about a case of any of the following diseases, the officer must ensure that a specimen from the case is submitted to the department, when possible, which will be analyzed to confirm the existence or absence of the disease in question, or for use in surveillance:

(a) Anthrax;

(b) Arboviral diseases, neuroinvasive and non-neuroinvasive (California serogroup, Chikungunya, Eastern equine encephalitis, Powassan, Saint Louis encephalitis, West Nile virus, Western equine encephalitis, Zika virus infection);

(c) Botulism;

(d) Brucellosis;

(e) Campylobacteriosis;

(f) Carbapenem-Resistant Enterobacteriaceae (CRE);

(g) Cholera;

(h) Diphtheria;

(i) Escherichia coli, shiga toxin-producing (STEC);

(j) Gonorrhea;

(k) Haemophilus influenzae invasive disease;

(l) Hantavirus pulmonary syndrome or infection;

(m) Human immunodeficiency virus (HIV);

(n) Influenza;

(o) Listeriosis;

(p) Measles (rubeola);

(q) Meningococcal disease (Neisseria meningitidis);

(r) Plague;

(s) Poliomyelitis, paralytic or non-paralytic;

(t) Rabies (human);

(u) Rubella (including congenital);

(v) Salmonellosis;

(w) Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) disease;

(x) Shigellosis;

(y) Smallpox;

(z) Syphilis;

(aa) Trichinellosis (Trichinosis);

(ab) Tuberculosis;

(ac) Tularemia;

(ad) Typhoid fever;

(ae) Vancomycin-intermediate staphylococcus aureus (VISA);

(af) Vancomycin-resistant staphylococcus aureus (VRSA); and

(ag) Vibriosis.

(2) In the event of an outbreak of an arboviral disease, gastroenteritis, influenza, measles, or pertussis, specimens must be submitted until a representative sample has been reached as determined by the department.

(3) A laboratory professional or any other person in possession of a specimen from a case of a disease listed in (1)(a) through (ag) must submit the specimen to the department upon request.

(4) If no specimen from the case is otherwise available and the case refuses to allow a specimen to be taken for purposes of (1), the case will be assumed to be infected and must comply with whatever control measures are imposed by the department, or the local health officer.

 

History: 50-1-202, 50-1-204, MCA; IMP, 50-1-202, 50-1-204, MCA; NEW, 1987 MAR p. 2147, Eff. 11/28/87; AMD, 1994 MAR p. 1295, Eff. 5/13/94; AMD, 1995 MAR p. 1127, Eff. 6/30/95; AMD, 2000 MAR p. 2528, Eff. 9/22/00; TRANS, from DHES, 2002 MAR p. 913; AMD, 2006 MAR p. 2112, Eff. 9/8/06; AMD, 2013 MAR p. 967, Eff. 6/7/13; AMD, 2017 MAR p. 343, Eff. 3/25/17.

Home  |   Search  |   About Us  |   Contact Us  |   Help  |   Disclaimer  |   Privacy & Security